GlucoTec Inc., a company out of Greenville, South Carolina, announced that it has received FDA clearance for its Glucommander Plus, a device that calculates and recommends titration protocols for dosing IV insulin, glucose, and saline in diabetics.
Now more on the device from the company’s site:
The Glucommander Plus is a FDA-approved class II medical device that provides patient management & system-wide quality improvement services for health care providers concerned with patient glycemic control.
The device (tablet or handheld versions available) enables licensed health care professionals to titrate dosing of insulin, glucose, saline and other medications for patients on intravenous and subcutaneous therapy and as a result, to reach target blood glucose levels more quickly and with fewer complications than other treatment methods.
The device captures data on the patient, as well as the caregivers (by attending MD, nurse, unit & hospital) that enables the provider to evaluate current delivery systems and identify opportunities for improving patient care.
The device has been clinically demonstrated through over 120,000 hours of use (& 5000 patients) to achieve glycemic control in 4-8 hours, with fewer adverse events (such as hypoglycemia & cerebral edema) than other methods. As a result of documented reductions in length-of-stay & comorbidities, hospitals using the device have experienced significant reductions in length of stay (cost of care) & improved productivity.